People who are recovering from tendon, ligament, or muscle injuries, with persistent gut disorders (IBD, ulcers, leaky gut), inflammation or tissue damage from NSAIDs, wanting speedier surgery or injury recovery, managing brain-gut dysfunction or systemic inflammation
Low Dose Naltrexone (LDN) Another treatment option discussed is Low Dose Naltrexone (LDN), a medication that has shown promise in reducing inflammation and modulating the immune system
The approval was based on data from the Phase III KarMMa-3 trial, where treatment with Abecma tripled the progression-free survival rate
Research has focused on its extended duration of action compared to native GHRH and its effects on GH secretion, IGF-1 levels, and body composition parameters
AOD-9604: marketed as a fat-loss fragment, did not beat placebo in its obesity trials (covered in the AOD-9604 fragment)
If that describes you, Henry Meds delivers a competitive option